"In the research roadmap, Dr. Drucker and his co-authors identified six broad research questions to better understand: the underlying mechanisms that cause obesity; the variability in types of obesity and treatment responses; identifying treatment targets that go beyond percentage weight loss; fat mass dynamics during the different phases of weight loss induced by obesity drugs; health outcomes for people who take GLP-1s; and the safety of these drugs going forward."
Framing: assertive ·
First seen: 2026-09-15 ·
Last seen: 2026-09-15 ·
Spread: 1 articles